What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature

Abstract

Background and Objectives: Acute hematologic malignancies are a group of heterogeneous blood diseases with a high mortality rate, mostly due to acute respiratory failure (ARF). Acute respiratory distress syndrome (ARDS) is one form of ARF which represents a challenging clinical condition. The paper aims to review current knowledge regarding the variable pathogenic mechanisms, as well as therapeutic options for ARDS in acute hematologic malignancy patients. Data collection: We provide an overview of ARDS in patients with acute hematologic malignancy, from an etiologic perspective. We searched databases such as PubMed or Google Scholar, including articles published until June 2022, using the following keywords: ARDS in hematologic malignancy, pneumonia in hematologic malignancy, drug-induced ARDS, leukostasis, pulmonary leukemic infiltration, pulmonary lysis syndrome, engraftment syndrome, diffuse alveolar hemorrhage, TRALI in hematologic malignancy, hematopoietic stem cell transplant ARDS, radiation pneumonitis. We included relevant research articles, case reports, and reviews published in the last 18 years. Results: The main causes of ARDS in acute hematologic malignancy are: pneumonia-associated ARDS, leukostasis, leukemic infiltration of the lung, pulmonary lysis syndrome, drug-induced ARDS, radiotherapy-induced ARDS, diffuse alveolar hemorrhage, peri-engraftment respiratory distress syndrome, hematopoietic stem cell transplantation-related ARDS, transfusion-related acute lung injury. Conclusions: The short-term prognosis of ARDS in acute hematologic malignancy relies on prompt diagnosis and treatment. Due to its etiological heterogeneity, precision-based strategies should be used to improve overall survival. Future studies should focus on identifying the relevance of such etiologic-based diagnostic strategies in ARDS secondary to acute hematologic malignancy.

The Omics Complexity in Sepsis: The Limits of the Personalized Medicine Approach

“…They also had the most frequent pulmonary dysfunction. Other hematologic malignancies could influence, however, the pulmonary response to an infection [ 86 ]. δ phenotype patients had more liver dysfunction and were the most likely to develop septic shock [ 85 ].…”

Acute Promyelocytic Leukemia and Severe Differentiation Syndrome in Pregnancy—A Management Challenge

“…Differentiation syndrome (DS), previously known as retinoic acid syndrome, is the main life-threatening complication associated with induction therapy, using differentiating agents in patients with APL, in the presence of leukemic blasts [ 9 ]. The syndrome is characterized by fever, acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), vascular capillary leak syndrome, and distributive shock, which requires supportive therapy [ 9 , 10 ].…”

Advances in Cancer Therapy from Research to Clinical Practice—Surgical, Molecular or Systemic Management of Cancer

“…Cotorogea-Simion et al [25] developed the mechanisms presumed to be implicated in the pathogenesis of respiratory insufficiency, which frequently occurs in hematologic diseases. We hope that the readers will find answers to their questions or read about a finding related to their scientific interest in our Special Issue.…”

“…Cotorogea-Simion et al [ 25 ] developed the mechanisms presumed to be implicated in the pathogenesis of respiratory insufficiency, which frequently occurs in hematologic diseases.…”